<p>/PRNewswire/ -- Healthcare Triangle, Inc.（纳斯达克代码：HCTI）（&#34;HCTI&#34;或&#34;公司&#34;），作为医疗和生命科学数字化转型解决方案的领导者，今天宣布已与 Teyame AI LLC（圣基茨和尼维斯公司）（&#34;Teyame&#34;）签署了一项预先协议，作为其计划收购西班牙公司 Teyame 360 SL 和 Datono Mediacion SL（&#34;资产&#34;）的一部分，这两家公司共同作为一家基于西班牙的 AI 驱动的全渠道客户体验（CX）解决方案的领导者。此次收购将使公司在 AI 驱动的客户和患者互动方面成为全球力量。</p>
<p>拟议交易的总对价预计约为 5000 万美元，由现金、公司普通股、非投票可转换优先股和基于业绩的权益对价组合构成，具体取决于最终的购买协议条款。各方目前预计在 2026 年第一季度完成交易，前提是谈判和签署最终购买协议、完成尽职调查、获得必要的股东批准以及其他常规成交条件。本次沟通不构成任何代理、投票或批准的征求。</p>
<p>根据公司从 Teyame 获得的财务信息，公司预计资产将在 2025 财年产生约 3400 万美元的增量年收入和 420 万美元的增量 EBITDA。计划中的收购代表了 HCTI 从医疗 IT 提供商向全面数字健康创新者演变的关键时刻，并预计将显著提升 HCTI 的财务表现和股东价值。</p>
<p><em>&#34;这笔交易将带来真实世界的 Agentic Gen AI 经验，并将改变 HCTI 的游戏规则。这是 AI 真正落地的地方&#34;</em> HCTI 首席财务官 David Ayanoglou 补充道。</p>
<p><em>&#34;我们很高兴通过签署具有约束力的预先协议迈出这一决定性步骤。将这些 AI 驱动的互动平台与 HCTI 的医疗技术整合，使我们能够为患者、提供者和全球市场提供下一代智能生态系统。&#34;</em> <em>—</em> HCTI 首席运营官、首席执行官及董事会董事 Sujatha Ramesh。</p>
<p>此次计划收购被视为 HCTI 更广泛战略中的关键一步，重点关注：</p>
<ul>
<li>AI 驱动的医疗创新。</li>
<li>面向患者互动和护理管理的全球 SaaS 平台。</li>
<li>通过数字优先的医疗解决方案扩展到高增长国际市场。</li>
</ul>
<p>此次战略收购将结合 HCTI 在医疗技术方面的深厚专业知识与收购资产的 AI 自动化客户互动平台，从而创建一个集成生态系统，使每个患者接触点都变得智能化、个性化，并以结果为导向。</p>
<p><strong>关于 Healthcare Triangle</strong></p>
<p>Healthcare Triangle, Inc.总部位于加利福尼亚州普莱森顿，通过突破性技术和广泛的行业知识与专业知识推动医疗进步。我们支持包括医院和健康系统、支付方以及制药/生命科学组织在内的医疗机构，帮助他们通过更好地利用依赖的数据和信息技术来改善健康结果。Healthcare Triangle 获得了云和数据平台（CaDP）的 HITRUST 认证，市场名称为 CloudEz™和 DataEz™。HITRUST 基于风险的 2 年（r2）认证状态向我们的客户展示了数据保护和信息安全的最高标准。Healthcare Triangle 促进新技术的采用、数据启蒙、业务灵活性以及对即时业务需求和竞争威胁的响应。高度监管的医疗和生命科学行业依赖 Healthcare Triangle 在数字化转型方面的专业知识，包括云、安全与合规、数据生命周期管理、医疗互操作性以及临床与业务绩效优化。</p>
<p><strong>关于 Teyame 360 SL 和 Datono Mediacion SL</strong></p>
<p>经过验证的 AI 创新和客户互动与医疗专业知识的结合</p>
<p>总部位于马德里的资产公司构建了一个复杂的平台，完美融合了人工智能与人类专业知识，目前为银行和保险客户提供服务，同时试点突破性的医疗应用。该公司的技术栈包括先进的聊天机器人自动化、多语言患者互动工具和实时分析，这些能力在与 HCTI 的临床系统集成时变得更加强大。</p>
<p>资产创新的主要亮点包括：</p>
<ul>
<li>将 Agentic 生成性 AI（Gen AI）集成到核心运营中。</li>
<li>先进的 AI 与人类协作模型以提高效率。</li>
<li>AI 驱动的医疗服务试点，如预约确认和多语言患者互动。</li>
<li>发展成为数字优先的 AI 驱动全球 CX 提供商。</li>
</ul>
<p><strong>前瞻性声明和安全港通知</strong></p>
<p>本新闻稿中除历史事实陈述以外的所有陈述均为 “前瞻性陈述”（根据 1995 年《私人证券诉讼改革法案》的定义），包括但不限于关于私募的完成、满足私募的惯常成交条件以及使用其收益的陈述。这些前瞻性陈述包括我们的预期以及使用 “预计”、“期望”、“可能性” 和 “预期” 等前瞻性词汇的陈述。实现或成功达成这些前瞻性陈述所涉及的事项存在重大风险、不确定性和假设，包括市场及其他条件。实际结果可能与当前的预测或隐含结果存在重大差异。投资者应阅读公司截至 2024 年 12 月 31 日的 10-K 表格年度报告中列出的风险因素，该报告已提交给证券交易委员会（“SEC”），以及之前的文件、后续文件和未来定期报告中提交给 SEC 的内容。所有公司的前瞻性陈述均受到所有这些风险因素和其他警示性陈述的明确限定。</p>
<p>投资者：</p>
<p>1-800-617-9550</p>
<p>ir@healthcaretriangle.com</p>
<p>来源：Healthcare Triangle, Inc.</p>

HCTI

<p>Healthcare Triangle, Inc. (HCTI) 已签署一项预先协议，以收购 Teyame AI LLC 的资产，使 HCTI 成为人工智能驱动的客户和患者互动领域的领导者。此次收购的估值高达 5000 万美元，预计将在 2026 年第一季度完成，并为 2025 财年带来 3400 万美元的收入。这一战略举措旨在提升 HCTI 的财务表现并扩大其全球市场影响力</p>

<p>, /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (&#34;HCTI&#34; or the &#34;Company&#34;), a leader in digital transformation solutions for healthcare and life sciences, today announces that it has entered into an Advance Agreement with Teyame AI LLC, a St Kitts and Nevis corporation (&#34;Teyame&#34;), as part of its planned acquisition of the shares of Teyame 360 SL and Datono Mediacion SL, companies incorporated in Spain (&#34;Assets&#34;), which are run together as a Spain-based leader in AI-powered omnichannel customer experience (CX) solutions. This acquisition would position the Company as a global force in AI-powered customer and patient engagement.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Healthcare Triangle, Inc.（纳斯达克代码：HCTI）（&#34;HCTI&#34;或&#34;公司&#34;），作为医疗和生命科学数字化转型解决方案的领导者，今天宣布已与 Teyame AI LLC（圣基茨和尼维斯公司）（&#34;Teyame&#34;）签署了一项预先协议，作为其计划收购西班牙公司 Teyame 360 SL 和 Datono Mediacion SL（&#34;资产&#34;）的一部分，这两家公司共同作为一家基于西班牙的 AI 驱动的全渠道客户体验（CX）解决方案的领导者。此次收购将使公司在 AI 驱动的客户和患者互动方面成为全球力量。</p>
</div><p>The proposed transaction contemplates up to approximately $50 million of total consideration, consisting of a combination of cash, shares of the Company's common stock, shares of non-voting convertible preferred stock, and contingent earnout-based equity consideration, subject to the final terms of a definitive purchase agreement. The parties currently anticipate targeting a closing in the first quarter of 2026, subject to the negotiation and execution of a definitive purchase agreement, completion of due diligence, required shareholder approval, and other customary closing conditions. This communication does not constitute a solicitation of any proxy, vote or approval.</p>
<div class="lb-trans"><p>拟议交易的总对价预计约为 5000 万美元，由现金、公司普通股、非投票可转换优先股和基于业绩的权益对价组合构成，具体取决于最终的购买协议条款。各方目前预计在 2026 年第一季度完成交易，前提是谈判和签署最终购买协议、完成尽职调查、获得必要的股东批准以及其他常规成交条件。本次沟通不构成任何代理、投票或批准的征求。</p>
</div><p>Based on financial information the Company has received from Teyame, the Company expects the Assets to generate approximately $34 million in incremental annual revenue and $4.2 million in incremental EBITDA for fiscal year 2025. The planned acquisition represents a pivotal moment in HCTI's evolution from healthcare IT provider to comprehensive digital health innovator and is expected to significantly enhance HCTI's financial performance and shareholder value.</p>
<div class="lb-trans"><p>根据公司从 Teyame 获得的财务信息，公司预计资产将在 2025 财年产生约 3400 万美元的增量年收入和 420 万美元的增量 EBITDA。计划中的收购代表了 HCTI 从医疗 IT 提供商向全面数字健康创新者演变的关键时刻，并预计将显著提升 HCTI 的财务表现和股东价值。</p>
</div><p><em>&#34;The transaction will bring real world lived experience of Agentic Gen AI and is about to change the game for HCTI. It's where the rubber meets the road in AI&#34;</em> added David Ayanoglou, Chief Financial Officer of HCTI <em>.</em></p>
<div class="lb-trans"><p><em>&#34;这笔交易将带来真实世界的 Agentic Gen AI 经验，并将改变 HCTI 的游戏规则。这是 AI 真正落地的地方&#34;</em> HCTI 首席财务官 David Ayanoglou 补充道。</p>
</div><p><em>'We are pleased to take this decisive step with the signing of the binding advance agreement. Integrating these AI-powered engagement platforms with HCTI's healthcare technologies positions us to deliver a next-generation, intelligent ecosystem for patients, providers, and global markets.&#34;</em> <em>—</em> Sujatha Ramesh, Chief Operating Officer, Principal Executive Officer, and Director, Board of Directors, HCTI.</p>
<div class="lb-trans"><p><em>&#34;我们很高兴通过签署具有约束力的预先协议迈出这一决定性步骤。将这些 AI 驱动的互动平台与 HCTI 的医疗技术整合，使我们能够为患者、提供者和全球市场提供下一代智能生态系统。&#34;</em> <em>—</em> HCTI 首席运营官、首席执行官及董事会董事 Sujatha Ramesh。</p>
</div><p>This planned acquisition is slated to be a critical step in HCTI's broader strategy focused on:</p>
<div class="lb-trans"><p>此次计划收购被视为 HCTI 更广泛战略中的关键一步，重点关注：</p>
</div><ul>
<li>AI-driven healthcare innovation.</li>
<li>Global SaaS platforms for patient engagement and care management.</li>
<li>Expansion into high-growth international markets through digital-first healthcare solutions.</li>
</ul>
<div class="lb-trans"><ul>
<li>AI 驱动的医疗创新。</li>
<li>面向患者互动和护理管理的全球 SaaS 平台。</li>
<li>通过数字优先的医疗解决方案扩展到高增长国际市场。</li>
</ul>
</div><p>This strategic acquisition will combine HCTI's deep healthcare technology expertise with the acquired Assets' AI automation customer engagement platform(s), so that an integrated ecosystem can be created where every patient touchpoint would become intelligent, personalized, and outcome focused.</p>
<div class="lb-trans"><p>此次战略收购将结合 HCTI 在医疗技术方面的深厚专业知识与收购资产的 AI 自动化客户互动平台，从而创建一个集成生态系统，使每个患者接触点都变得智能化、个性化，并以结果为导向。</p>
</div><p><strong>About Healthcare Triangle</strong></p>
<div class="lb-trans"><p><strong>关于 Healthcare Triangle</strong></p>
</div><p>Healthcare Triangle, Inc. based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare organizations including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes through better utilization of the data and information technologies that they rely on. Healthcare Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical &amp; business performance optimization.</p>
<div class="lb-trans"><p>Healthcare Triangle, Inc.总部位于加利福尼亚州普莱森顿，通过突破性技术和广泛的行业知识与专业知识推动医疗进步。我们支持包括医院和健康系统、支付方以及制药/生命科学组织在内的医疗机构，帮助他们通过更好地利用依赖的数据和信息技术来改善健康结果。Healthcare Triangle 获得了云和数据平台（CaDP）的 HITRUST 认证，市场名称为 CloudEz™和 DataEz™。HITRUST 基于风险的 2 年（r2）认证状态向我们的客户展示了数据保护和信息安全的最高标准。Healthcare Triangle 促进新技术的采用、数据启蒙、业务灵活性以及对即时业务需求和竞争威胁的响应。高度监管的医疗和生命科学行业依赖 Healthcare Triangle 在数字化转型方面的专业知识，包括云、安全与合规、数据生命周期管理、医疗互操作性以及临床与业务绩效优化。</p>
</div><p><strong>About</strong> <strong>Teyame 360 SL and Datono</strong> <strong>Mediacion SL</strong></p>
<div class="lb-trans"><p><strong>关于 Teyame 360 SL 和 Datono Mediacion SL</strong></p>
</div><p>Proven AI Innovation and Customer Engagement Meets Healthcare Expertise</p>
<div class="lb-trans"><p>经过验证的 AI 创新和客户互动与医疗专业知识的结合</p>
</div><p>The Assets which are headquartered in Madrid, have built a sophisticated platform that seamlessly blends artificial intelligence with human expertise, currently serving banking and insurance clients while piloting breakthrough healthcare applications. The company's technology stack includes advanced chatbot automation, multilingual patient engagement tools, and real-time analytics, capabilities that become exponentially more powerful when integrated with HCTI's clinical systems.</p>
<div class="lb-trans"><p>总部位于马德里的资产公司构建了一个复杂的平台，完美融合了人工智能与人类专业知识，目前为银行和保险客户提供服务，同时试点突破性的医疗应用。该公司的技术栈包括先进的聊天机器人自动化、多语言患者互动工具和实时分析，这些能力在与 HCTI 的临床系统集成时变得更加强大。</p>
</div><p>Key highlights of the Assets' innovations include:</p>
<div class="lb-trans"><p>资产创新的主要亮点包括：</p>
</div><ul>
<li>Integration of Agentic Generative AI (Gen AI) into core operations.</li>
<li>Advanced AI-human collaboration models to drive efficiency.</li>
<li>Pilots of AI-powered healthcare services, such as appointment confirmations and multilingual patient engagement.</li>
<li>Evolution into a digital-first, AI-powered global CX provider.</li>
</ul>
<div class="lb-trans"><ul>
<li>将 Agentic 生成性 AI（Gen AI）集成到核心运营中。</li>
<li>先进的 AI 与人类协作模型以提高效率。</li>
<li>AI 驱动的医疗服务试点，如预约确认和多语言患者互动。</li>
<li>发展成为数字优先的 AI 驱动全球 CX 提供商。</li>
</ul>
</div><p><strong>Forward-Looking Statements and Safe Harbor Notice</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明和安全港通知</strong></p>
</div><p>All statements other than statements of historical facts included in this press release are &#34;forward-looking statements&#34; (as defined in the Private Securities Litigation Reform Act of 1995), and include, among others, statements regarding the consummation of the private placement, satisfaction of the customary closing conditions of the private placement and the use of the proceeds therefrom. Such forward-looking statements include our expectations and those statements that use forward-looking words such as &#34;projected,&#34; &#34;expect,&#34; &#34;possibility&#34; and &#34;anticipate.&#34; The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties, and assumptions, including market and other conditions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors out lined in the company's annual report on form 10-K for the year ended December 31, 2024, on file with the Securities Exchange Commission (the &#34;SEC&#34;) and in previous filings, subsequent filings and future periodic reports filed with the SEC. All the company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.</p>
<div class="lb-trans"><p>本新闻稿中除历史事实陈述以外的所有陈述均为 “前瞻性陈述”（根据 1995 年《私人证券诉讼改革法案》的定义），包括但不限于关于私募的完成、满足私募的惯常成交条件以及使用其收益的陈述。这些前瞻性陈述包括我们的预期以及使用 “预计”、“期望”、“可能性” 和 “预期” 等前瞻性词汇的陈述。实现或成功达成这些前瞻性陈述所涉及的事项存在重大风险、不确定性和假设，包括市场及其他条件。实际结果可能与当前的预测或隐含结果存在重大差异。投资者应阅读公司截至 2024 年 12 月 31 日的 10-K 表格年度报告中列出的风险因素，该报告已提交给证券交易委员会（“SEC”），以及之前的文件、后续文件和未来定期报告中提交给 SEC 的内容。所有公司的前瞻性陈述均受到所有这些风险因素和其他警示性陈述的明确限定。</p>
</div><p>Investors:</p>
<div class="lb-trans"><p>投资者：</p>
</div><p>1-800-617-9550</p>
<div class="lb-trans"><p>1-800-617-9550</p>
</div><p>ir@healthcaretriangle.com</p>
<div class="lb-trans"><p>ir@healthcaretriangle.com</p>
</div><p>SOURCE Healthcare Triangle, Inc.</p>
<div class="lb-trans"><p>来源：Healthcare Triangle, Inc.</p>
</div>

Healthcare Triangle, Inc. Signs Advance Agreement for the Acquisition of Next-Generation AI Customer Engagement Business, on track to generate $34M in Revenue for FY 2025 | HCTI Stock News

Healthcare Triangle, Inc.签署了收购下一代 AI 客户互动业务的预先协议，预计将在 2025 财年实现 3400 万美元的收入 | HCTI 股票新闻